Browsing by Author Kanokrungsee S.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

or enter first few letters:  
Showing results 4 to 21 of 21 < previous 
Issue DateTitleAuthor(s)
2022Can mRNA COVID-19 vaccines induce flares of chronic urticaria?Kanokrungsee S.; Naruenatwanich C.
2023Can mRNA COVID-19 vaccines induce flares of chronic urticaria?Kanokrungsee S.; Naruenatwanich C.; Srinakharinwirot University
2019Clear cell papulosis: Dermatoscopic findings and literature reviewLeerunyakul K.; Kanokrungsee S.; Rutnin S.
2021Clinical outcomes of topical bimatoprost for nonsegmental facial vitiligo: A preliminary studyKanokrungsee S.; Pruettivorawongse D.; Rajatanavin N.
2020Clinical outcomes of topical bimatoprost for nonsegmental facial vitiligo: A preliminary studyKanokrungsee S.; Pruettivorawongse D.; Rajatanavin N.
2021Comparison between the use of intense pulsed light and Q-switched neodymium-doped yttrium aluminum garnet laser for the treatment of axillary hyperpigmentationAmornpetkul W.; Kanokrungsee S.; Kamanamool N.; Udompataikul M.; Rojhirunsakool S.
2020Comparison of the effectiveness of fractional 1550-nm erbium fiber laser and 0.05% tretinoin cream in the treatment of acanthosis nigricans: a prospective, randomized, controlled trialLeerapongnan P.; Jurairattanaporn N.; Kanokrungsee S.; Udompataikul M.
2021Detachable dissolvable microneedles: intra-epidermal and intradermal diffusion, effect on skin surface, and application in hyperpigmentation treatmentSawutdeechaikul P.; Kanokrungsee S.; Sahaspot T.; Thadvibun K.; Banlunara W.; Limcharoen B.; Sansureerungsikul T.; Rutwaree T.; Oungeun M.; Wanichwecharungruang S.
2021Efficacy and safety of a novel water-soluble herbal patch for acne vulgaris treatment: A randomized, assessor-blinds controlled, intra-individual split-face comparative studyJaturapisanukul K.; Udompataikul M.; Kanokrungsee S.; Rojhirunsakool S.; Kamanamool N.; Rachpirom M.; Puttarak P.
2020Efficacy and tolerability of 20% aluminum sesquichlorohydrate vs 20% aluminum chloride for the treatment of axillary hyperhidrosis: A randomized controlled trialThianboonsong T.; Kanokrungsee S.; Paichitrojjana A.; Udompataikul M.; Kamanamool N.; Rojhirunsakool S.
2022Efficacy of probiotic-derived lotion from Lactobacillus paracasei MSMC 39-1 in mild to moderate acne vulgaris, randomized controlled trialSathikulpakdee S.; Kanokrungsee S.; Vitheejongjaroen P.; Kamanamool N.; Udompataikul M.; Taweechotipatr M.
2020Low-fluence Q-switched Nd:YAG 1064-nm laser versus Q-switched Nd:YAG 532-nm laser in the treatment of hyperpigmented lips: a prospective, randomized, controlled, evaluator-blinded trialLimpjaroenviriyakul N.; Jurairattanaporn N.; Kamanamool N.; Rojhirunsakool S.; Kanokrungsee S.; Udompataikul M.
2021Rituximab therapy for treatment of pemphigus in Southeast AsiansKanokrungsee S.; Anuntrangsee T.; Tankunakorn J.; Srisuwanwattana P.; Suchonwanit P.; Chanprapaph K.
2020The behavior, attitude, and knowledge towards photoprotection in patients with cutaneous/systemic lupus erythematosus: a comparative study with 526 patients and healthy controlsChanprapaph K.; Ploydaeng M.; Pakornphadungsit K.; Mekwilaiphan T.; Vachiramon V.; Kanokrungsee S.
2021The comparative study of efficacy between 1064-nm long-pulsed Nd:YAG laser and 595-nm pulsed dye laser for the treatment of acne vulgarisChalermsuwiwattanakan N.; Rojhirunsakool S.; Kamanamool N.; Kanokrungsee S.; Udompataikul M.
2020The comparative study of efficacy between 1064-nm long-pulsed Nd:YAG laser and 595-nm pulsed dye laser for the treatment of acne vulgarisChalermsuwiwattanakan N.; Rojhirunsakool S.; Kamanamool N.; Kanokrungsee S.; Udompataikul M.
2023The efficacy of a transdermal hydrogel patch containing betamethasone dipropionate for treatment of chronic hand eczema: A single-blind, randomized and controlled trialThaitirarot S.; Shuwisitkul D.; Udompataikul M.; Kamanamool N.; Kanokrungsee S.; Srinakharinwirot University
2022Triple combination therapy of narrowband ultraviolet B, fractional carbon dioxide laser and topical bimatoprost 0.01% for non-segmental vitiligo on non-facial areas: A randomized half-body, double-blind, placebo-controlled, comparative studyKanokrungsee S.; Khunkhet S.; Rojhirunsakool S.; Thadvibun K.; Sahaspot T.